Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-27
2009-10-06
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S229000, C544S249000, C544S250000, C544S253000, C544S280000, C544S295000, C544S279000, C544S242000, C544S284000, C544S283000, C540S578000
Reexamination Certificate
active
07598255
ABSTRACT:
Certain pyrimidine-containing compounds are serotonin receptor modulators useful in the treatment of serotonin-mediated diseases.
REFERENCES:
patent: 3312716 (1967-04-01), Biel et al.
patent: 3969355 (1976-07-01), Schwan
patent: 4007196 (1977-02-01), Christensen et al.
patent: 4136193 (1979-01-01), Bogeso et al.
patent: 4314081 (1982-02-01), Molloy et al.
patent: 4536518 (1985-08-01), Welch et al.
patent: 4576604 (1986-03-01), Guittard et al.
patent: 4673405 (1987-06-01), Guittard et al.
patent: 4857330 (1989-08-01), Stephens et al.
patent: 5137890 (1992-08-01), Sanfilippo et al.
patent: 5405848 (1995-04-01), Sanfilippo et al.
patent: 5997905 (1999-12-01), McTeigue et al.
patent: 6025367 (2000-02-01), Forbes et al.
patent: 6149943 (2000-11-01), McTeigue et al.
patent: 6355642 (2002-03-01), Koyama et al.
patent: 6407112 (2002-06-01), Koyama et al.
patent: 6414149 (2002-07-01), Chu-Moyer et al.
patent: 2002/0183519 (2002-12-01), Nar et al.
patent: 2003/0153728 (2003-08-01), Kolb et al.
patent: 2004/0229874 (2004-11-01), Bright et al.
patent: 2005/0119295 (2005-06-01), Carruthers et al.
patent: 2005/0232986 (2005-10-01), Brown et al.
patent: 2005/0288355 (2005-12-01), Mork et al.
patent: 2006/0194837 (2006-08-01), Carruthers et al.
patent: 2006/0287292 (2006-12-01), Carruthers et al.
patent: 2006/0293316 (2006-12-01), Apodaca et al.
patent: 2007/0260057 (2007-11-01), Deng et al.
patent: 2008/0004258 (2008-01-01), Keith et al.
patent: 2008/0045508 (2008-02-01), Allison et al.
patent: 2008/0045509 (2008-02-01), Allison et al.
patent: 1264820 (2002-12-01), None
patent: 1211246 (2004-02-01), None
patent: 03 148265 (1991-06-01), None
patent: 03148265 (1991-06-01), None
patent: WO 95/29909 (1995-11-01), None
patent: WO 96/32944 (1996-10-01), None
patent: WO 97/29097 (1997-08-01), None
patent: WO 97/47601 (1997-12-01), None
patent: WO 97/48681 (1997-12-01), None
patent: WO 97/49695 (1997-12-01), None
patent: WO 98/31354 (1998-07-01), None
patent: WO 99/24022 (1999-05-01), None
patent: WO 00/32173 (2000-06-01), None
patent: WO 00/37082 (2000-06-01), None
patent: WO 00/56712 (2000-09-01), None
patent: WO 00/59510 (2000-10-01), None
patent: WO 00/73299 (2000-12-01), None
patent: WO 01/29029 (2001-04-01), None
patent: WO 01/41766 (2001-06-01), None
patent: WO 01/57039 (2001-08-01), None
patent: WO 02/14314 (2002-02-01), None
patent: WO 02/062788 (2002-08-01), None
patent: WO 02/072558 (2002-09-01), None
patent: WO 02072558 (2002-09-01), None
patent: WO 03/035070 (2003-05-01), None
patent: WO 03/053330 (2003-07-01), None
patent: WO 03053330 (2003-07-01), None
patent: WO 2004/011467 (2004-02-01), None
patent: WO 2004011467 (2004-02-01), None
patent: WO 2004094419 (2004-04-01), None
patent: WO 2004/039786 (2004-05-01), None
patent: WO 2004039786 (2004-05-01), None
patent: WO 2004/094419 (2004-11-01), None
patent: WO 2005/005387 (2005-01-01), None
patent: WO 2005/030132 (2005-04-01), None
patent: WO 2005/056056 (2005-06-01), None
patent: WO 2006/016262 (2006-02-01), None
patent: WO 2008/013556 (2008-01-01), None
Appell, et al., Bioorganic & Medicinal Chemistry (2002), 10(5), 1197-1206.
Herrera, et al., Magnetic Resonance in Chemistry (2002), 40(4), 293-299.
Garcia Martinez, et al., Tetrahedron (1998), 54(18), 4607-4614.
Kawamura, et al., Bioscience, Biotechnology, and Biochemistry (1992), 56(11), 1897-9.
Collier, et al., Science of Synthesis (2004), 19, 403-425.
Voitenko, et al., Phosphorus, Sulfur and Silicon and the Related Elements (2005), 180(1), 163-177.
Herrera, et al., Tetrahedron Letters (2003), 44(10), 2149-2151.
Herrera, et al., Tetrahedron (2002), 58(19), 3755-3764.
Lafferty, et al., Journal of Organic Chemistry (1967), 32(5), 1591-6.
Poyurovsky, et al., Euro. Neuropsychopharmacol. 13 (2003) 123-128.
Kim, et al., Molec. & Cellular Probes (2000) 14, 47-52.
Khawam, et al., Cleveland Clinic J. Med., vol. 73, # 4, Apr. 2006, 351-361.
Mendelson, J. Clin. Psychiatry 2005: 66, 469-476.
Silvestre, et al., Methods Find Exp Clin Pharmacol 2005, 27(5): 289.
Kast, Support Care Cancer (2001) 9:469-470.
Naranjo, et al., Addiction, vol. 90, # 7, pp. 893-905, Jul. 1995.
May, et al., J. Pharmacol. & Experim. Therap., Apr. 3, 2003.
PCT International Search Report for International Application No. PCT/US2006/029437 dated Dec. 14, 2006.
Appell, M. et al. An analysis of the binding of cocaine analogues to the monamine transporters using tensor decomposition 3-D QSAR. Bioorg. Med. Chem. 2002, 10(5), 1197-1206.
Berge, S.M. et al. Pharmaceutical Salts. J. Pharm. Sci., 1977, 66:1-19.
Bonhaus, D.W. et al. RS-127443: A selective, high affinity, orally bioavailable 5-HT 2B receptor antagonist. Br. J. Pharmacol. 1999, 127(5), 1075-1082.
DeRuiter, J. et al. Investigation of the Synthesis and Analgesic Activity of 1-Substituted 4-(Propananilido)perhydroazepines. J. Het. Chem. 1992, 29(4), 779-786.
Dube, H. et al. Synthesis of chiral alpha-aminoalkylpyrimidines using an enantioselective three-component reaction. Synthesis 2004, 12, 2015-2025.
Herrera, A. et al.1H and13C NMR spectral assignments of 2,4-diaryl-substituted cycloalkyl[d]pyrimidines. Magn. Reson. Chem. 2002, 40(4), 293-299.
Herrera, A. et al. On the mechanism of reaction between ketones and nitriles. Unexpected results from benzyl nitriles. Tetrahedron 2002, 58(19), 3755-3764.
Hoyer, D. et al. Molecular, Pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 2002, 71, 533-554.
Jerman, J.C. et al. Pharmacological characterisation of human 5-HT2receptor subtypes. Eur. J. Pharmacol. 2001, 414, 23-30.
Kawamura, S. et al. Fused heterocycles, furo[3,2-d]pyrimidines and dihydrocyclopenta[d]pyrimidines, as potential new herbicides. Biosci. Biotechnol. Biochem. 1992, 56(11), 1897-1899.
Porter, R.H. et al. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2Band 5-HT2Creceptors in CHO-K1 cells. Br. J. Pharmacol. 1999, 128, 13-20.
Roth, B.L. et al. The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches? Neuroscientist 2000, 6(4), 252-262.
Sanfilippo et al. Novel tetrahydropyrido[4,3-d]pyrimidines as gastric antilesion agents. Eur. J. Med. Chem. 1992, 27(7), 655-661.
Schotte, A. et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 1996, 124, 57-73.
Stolle, W.A.W. et al. Intramolecular Diels-Alder reactions of pyrimidines: Synthesis of tricyclic annelated pyridines. Tetrahedron 1989, 45(20), 6511-6518.
Voitenko, Z.V. et al. Conversions of 2-(2-oxocycloehxylcarbonyl)benzoic acid derivatives to pyrazolo[5,1-a]isoindole and pyrimidine rings. Phosphorus, Sulfur Silicon Relat. Elem. 2005, 180(1), 163-177.
U.S. Appl. No. 60/938,790, filed May 18, 2007, Keith.
U.S. Appl. No. 11/939,881, filed Nov. 14, 2007, Keith et al.
Bard et al. Cloning of a Novel Human Serotonin Receptor (5-HT7) Positively Linked to Adenylate Cyclase. J. Biol. Chem. 1993, 268(31), 23422-23426.
Bonaventure et al. Radioligand Binding Analysis of Knockout Mice Reveals 5-Hydroxytryptamine7Receptor Distribution and Uncovers 8-Hydroxy-2-(2-di-N-propylamino)tetralin Interaction with α2 Adrenergic Receptors. Neuroscience 2004, 124, 901-911.
Bonnet, U. Moclobemide: Evolution, Pharmacokinetic, and Pharmacodynamic Properties. CNS Drug Rev. 2002, 8(3), 283-308.
Bymaster et al. Fluoxetine, but not other selective serotonin reuptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berlin) 2002, 160(4), 353-361.
Chen et al. P-Glycoprotein Limits the Brain Penetration of Nonsedating but Not Sedating H1-Antagonists. Drug Metab. Dispos. 2003, 31(3), 312-318.
Collier et al. Applications of Nitriles as Reagents for Organic Synthesis with the Loss of the Nitrile Functionality (including Cycloaddition Reactions). Science of Synthesis 2004, 19, 403-425.
Eglen et al. The 5-HT7Receptor: Orphan Found. Trends Pharmacol. Sci. 1997, 18, 104-107.
Frazer, A. Serotonergic and Noradrenergic Reuptake Inhibitors: Prediction of Clinical Effects from In Vitro Potencies. J. Clin. Psy
Atkins Michael J.
Berch Mark L
Jaisle Cecilia M
Janssen Pharmaceutica NV
LandOfFree
Pyrimidine compounds as serotonin receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine compounds as serotonin receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine compounds as serotonin receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4079098